Literature DB >> 19011186

Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study.

Alain Luciani1, Alexandre Vignaud, Madeleine Cavet, Jeanne Tran Van Nhieu, Ariane Mallat, Lucile Ruel, Alexis Laurent, Jean-François Deux, Pierre Brugieres, Alain Rahmouni.   

Abstract

PURPOSE: To retrospectively evaluate a respiratory-triggered diffusion-weighted (DW) magnetic resonance (MR) imaging sequence combined with parallel acquisition to allow the calculation of pure molecular-based (D) and perfusion-related (D*, f) diffusion parameters, on the basis of the intravoxel incoherent motion (IVIM) theory, to determine if these parameters differ between patients with cirrhosis and patients without liver fibrosis.
MATERIALS AND METHODS: The institutional review board approved this retrospective study; informed consent was waived. IVIM DW imaging was tested on three alkane phantoms, on which the signal-intensity decay curves according to b factors were logarithmically plotted. Ten b factors (0, 10, 20, 30, 50, 80, 100, 200, 400, 800 sec/mm(2)) were used in patients. Patients with documented liver cirrhosis (cirrhotic liver group, n = 12) and patients without chronic liver disease (healthy liver group, n = 25) were included. The mean liver D, D*, and f values were measured and compared with the apparent diffusion coefficient (ADC) computed by using four b values (0, 200, 400, 800 sec/mm(2)). Liver ADC and D, f, and D* parameters were compared between the cirrhotic liver group and healthy liver group. Means were compared by using the Student t test.
RESULTS: Signal-intensity decay curves were monoexponential on phantoms and biexponential in patients. In vivo, mean ADC values were significantly higher than D in the healthy liver group (ADC = 1.39 x 10(-3) mm(2)/sec +/- 0.2 [standard deviation] vs D = 1.10 x 10(-3) mm(2)/sec +/- 0.7) and in the cirrhotic liver group (ADC = 1.23 x 10(-3) mm(2)/sec +/- 0.4 vs D = 1.19 x 10(-3) mm(2)/sec +/- 0.5) (P = .03). ADC and D* were significantly reduced in the cirrhotic liver group compared with those in the healthy liver group (respective P values of .03 and .008).
CONCLUSION: Restricted diffusion observed in patients with cirrhosis may be related to D* variations, which reflect decreased perfusion, as well as alterations in pure molecular water diffusion in cirrhotic livers. RSNA, 2008

Entities:  

Mesh:

Year:  2008        PMID: 19011186     DOI: 10.1148/radiol.2493080080

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  221 in total

1.  Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hironobu Sou; Katsuhiro Sano; Ali Muhi; Richard L Ehman; Tsutomu Araki
Journal:  Magn Reson Imaging       Date:  2011-09-19       Impact factor: 2.546

2.  Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model.

Authors:  Sungheon Kim; Lindsey Decarlo; Gene Y Cho; Jens H Jensen; Daniel K Sodickson; Linda Moy; Silvia Formenti; Robert J Schneider; Judith D Goldberg; Eric E Sigmund
Journal:  NMR Biomed       Date:  2011-11-09       Impact factor: 4.044

3.  Diffusion-prepared fast imaging with steady-state free precession (DP-FISP): a rapid diffusion MRI technique at 7 T.

Authors:  Lan Lu; Bernadette Erokwu; Gregory Lee; Vikas Gulani; Mark A Griswold; Katherine M Dell; Chris A Flask
Journal:  Magn Reson Med       Date:  2011-12-02       Impact factor: 4.668

4.  The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study.

Authors:  Maïté Lewin; Laetitia Fartoux; Alexandre Vignaud; Lionel Arrivé; Yves Menu; Olivier Rosmorduc
Journal:  Eur Radiol       Date:  2010-08-05       Impact factor: 5.315

5.  Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Taoufik El-Gnaoui; Alexandre Vignaud; Pauline Beaussart; Shih-jui Lin; Karim Belhadj; Pierre Brugières; Eva Evangelista; Corinne Haioun; Michel Meignan; Alain Rahmouni
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

Review 6.  Liver diffusion-weighted MR imaging: the tower of Babel?

Authors:  Boris Guiu; Jean-Pierre Cercueil
Journal:  Eur Radiol       Date:  2010-11-26       Impact factor: 5.315

7.  Cardiac motion in diffusion-weighted MRI of the liver: artifact and a method of correction.

Authors:  Joy Liau; Jimmy Lee; Michael E Schroeder; Claude B Sirlin; Mark Bydder
Journal:  J Magn Reson Imaging       Date:  2011-09-29       Impact factor: 4.813

8.  Effects of perfusion on diffusion changes in human brain tumors.

Authors:  Alexander D Cohen; Peter S LaViolette; Melissa Prah; Jennifer Connelly; Mark G Malkin; Scott D Rand; Wade M Mueller; Kathleen M Schmainda
Journal:  J Magn Reson Imaging       Date:  2013-02-06       Impact factor: 4.813

Review 9.  Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.

Authors:  Suraj D Serai; Andrew T Trout; Alexander Miethke; Eric Diaz; Stavra A Xanthakos; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

10.  Diffusion analysis with triexponential function in hepatic steatosis.

Authors:  Tatsuya Hayashi; Tosiaki Miyati; Junji Takahashi; Yoshinori Tsuji; Hidesato Suzuki; Naomi Tagaya; Mariko Hiramoto; Kei Fukuzawa; Masakatsu Tano; Satoshi Saitoh
Journal:  Radiol Phys Technol       Date:  2013-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.